Editors' ChoiceCancer

A GEMA of a personalized medicine strategy

See allHide authors and affiliations

Science Translational Medicine  24 May 2017:
Vol. 9, Issue 391, eaan4294
DOI: 10.1126/scitranslmed.aan4294

You are currently viewing the abstract.

View Full Text


A screening method can identify tumors susceptible to synthetic lethality via PARP inhibition.

View Full Text